With the analysis among 10,862 patents, we discovered top 463 key players by total patent application. GlaxoSmithKline Biologicals SA, Changsha Xiehaoji Biological Engineering Co., Ltd., Amorepacific Corp. are dominant in this area. They take 6.11% of the total patent filing.
GlaxoSmithKline Biologicals SA
Changsha Xiehaoji Biological Engineering Co., Ltd.
Hunan Sheng, China
Patent: 137
Tasly Pharmaceutical Group Co., Ltd.
Tianjin Shi, China
Patent: 98
New Jersey, United States
Patent: 93
Utrecht, Netherlands
Patent: 91
Qingdao Century Star Language Communication Technology Co., Ltd.
Shandong Sheng, China
Patent: 59
Massachusetts, United States
Patent: 59
Adjuvance Technologies, Inc.
Nebraska, United States
Patent: 54
New South Wales, Australia
Patent: 46
With the analysis among 120 patents, we discovered top 13 start-ups by total patent application. Sapreme Technologies BV, Nil Co., Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
Utrecht, Netherlands
Patent: 91
Kanagawa-ken, Japan
Patent: 8
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 2
POP Biotechnologies, Inc.
New York, United States
Patent: 2
Abolis Biotechnologies SAS
With the analysis among related 4,630 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Sapreme Technologies BV, GlaxoSmithKline Biologicals SA, Adjuvance Technologies, Inc. take 4.13% of patent filing during this period.
Utrecht, Netherlands
Patent: 91
GlaxoSmithKline Biologicals SA
Adjuvance Technologies, Inc.
Nebraska, United States
Patent: 44
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 33
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 32
Guangxi Xinhai Pharmaceutical Technology Co., Ltd.
Guangxi Zhuangzu Zizhiqu, China
Patent: 26
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 24
Texas, United States
Patent: 24
Yunnan Agricultural University
Yunnan Sheng, China
Patent: 24
Guangzhou Degu Personal Care Products Co., Ltd.
Guangdong Sheng, China
Patent: 23
With the analysis among related 4,630 patents in last 5 years, we discover 253 new entrants. Sapreme Technologies BV, Guangxi Xinhai Pharmaceutical Technology Co., Ltd., Foshan Aurora Biotechnology Co., Ltd. are the most active new entrants in this area.
Utrecht, Netherlands
Patent: 91
Guangxi Xinhai Pharmaceutical Technology Co., Ltd.
Guangxi Zhuangzu Zizhiqu, China
Patent: 26
Foshan Aurora Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 15
Taizhou Medical City Guokehua Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 14
Grand Theravac Life Science (Nanjing) Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Yunnan Sheng, China
Patent: 10
Luxi County Xinfeida Biochemical Co., Ltd.
Hunan Sheng, China
Patent: 10
Jiangxi Jiusheng Camellia Development Co., Ltd.
Jiangxi Sheng, China
Patent: 9
Variation Biotechnologies, Inc. (Canada)
With the analysis among 3,894 patents, we discovered top 277 universities and scientific research institutions by total patent application. Zhejiang University, China Pharmaceutical University, Jilin Agricultural University are dominant in this area. They take 5.65% of the total patent filing.
Zhejiang Sheng, China
Patent: 79
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 79
Jilin Agricultural University
Jilin Sheng, China
Patent: 62
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 54
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 51
Jiangsu Sheng, China
Patent: 42
Jilin Sheng, China
Patent: 40
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 38
Yunnan Agricultural University
Yunnan Sheng, China
Patent: 36
South China Agricultural University
Guangdong Sheng, China
Patent: 35